L.p. 667, - Net Worth and Insider Trading

L.p. 667, Net Worth

The estimated net worth of L.p. 667, is at least $17 Million dollars as of 2024-04-27. L.p. 667, is the Director of ACADIA Pharmaceuticals Inc and owns about 1,045,475 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $17 Million. Details can be seen in L.p. 667,'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that L.p. 667, has not made any transactions after 2013-01-18 and currently still holds the listed stock(s).

Transaction Summary of L.p. 667,

To

L.p. 667, Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, L.p. 667, owns 21 companies in total, including IGM Biosciences Inc (IGMS) , Incyte Corp (INCY) , and Kodiak Sciences Inc (KOD) among others .

Click here to see the complete history of L.p. 667,’s form 4 insider trades.

Insider Ownership Summary of L.p. 667,

Ticker Comapny Transaction Date Type of Owner
IGMS IGM Biosciences Inc 2022-03-12 director & 10 percent owner
INCY Incyte Corp 2013-06-11 director
KOD Kodiak Sciences Inc 2022-01-21 director & 10 percent owner
PRLD Prelude Therapeutics Inc 2022-06-17 director & 10 percent owner
KNSA Kiniksa Pharmaceuticals Ltd 2022-06-29 director
BGNE BeiGene Ltd 2016-02-02 director & 10 percent owner
ACAD ACADIA Pharmaceuticals Inc 2013-01-18 director
SGEN Seagen Inc 2020-12-31 director & 10 percent owner
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director
ZYME Zymeworks Inc 2020-03-16 director
NLTX Neoleukin Therapeutics Inc 2015-08-07 10 percent owner
ACGN Aceragen Inc 2014-03-10 director
XOMA XOMA Corp 2012-07-19 director
MRTX Mirati Therapeutics Inc 2015-01-29 10 percent owner
BCRX BioCryst Pharmaceuticals Inc 2013-08-01 10 percent owner
XOMAO.PFD XOMA Corp 2012-07-19 director
TLIS Talis Biomedical Corp 2022-06-10 director & 10 percent owner
DBVT DBV Technologies SA 2022-06-13 director & 10 percent owner
SYRE Spyre Therapeutics Inc 2021-02-23 director
TCRX TScan Therapeutics Inc 2022-05-10 director & 10 percent owner
MDGL Madrigal Pharmaceuticals Inc 2023-06-15 director

L.p. 667, Latest Holdings Summary

L.p. 667, currently owns a total of 1 stock. L.p. 667, owns 1,045,475 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 18, 2013, with a value of $17 Million.

Latest Holdings of L.p. 667,

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2013-01-18 1,045,475 16.71 17,469,887

Holding Weightings of L.p. 667,


L.p. 667, Form 4 Trading Tracker

According to the SEC Form 4 filings, L.p. 667, has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 0 shares on January 18, 2013, which brought L.p. 667, around $0.

Insider Trading History of L.p. 667,

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

L.p. 667, Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

L.p. 667, Ownership Network

Ownership Network List of L.p. 667,

No Data

Ownership Network Relation of L.p. 667,


L.p. 667, Owned Company Details

What does IGM Biosciences Inc do?

Who are the key executives at IGM Biosciences Inc?

L.p. 667, is the director & 10 percent owner of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include director & 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Steven Weber , and Chief Medical Officer Chris H Takimoto .

IGM Biosciences Inc (IGMS) Insider Trades Summary

Over the past 18 months, L.p. 667, made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 11,918 shares made by George Gauthier , a net sale of 20,975 shares made by Bruce Keyt , and a net sale of 14,987 shares made by Lisa Lynn Decker .

In summary, during the past 3 months, insiders sold 28,125 shares of IGM Biosciences Inc (IGMS) in total and bought 395,317 shares, with a net purchase of 367,192 shares. During the past 18 months, 204,745 shares of IGM Biosciences Inc (IGMS) were sold and 1,190,933 shares were bought by its insiders, resulting in a net purchase of 986,188 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

IGM Biosciences Inc Insider Transactions

No Available Data

L.p. 667, Mailing Address

Above is the net worth, insider trading, and ownership report for L.p. 667,. You might contact L.p. 667, via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.

Discussions on L.p. 667,

No discussions yet.